Vaccine peptide combinations

A pharmaceutical formulation comprising a pharmaceutically acceptable carrier or diluent, a preservative, and, as the only therapeutic ingredients:

• the polypeptide which consists of the sequence of SEQ ID NO:
• 1;
• the polypeptide which consists of the sequence of SEQ ID NO:
• 2;
• the polypeptide which consists of the sequence of SEQ ID NO:
• 3;
• the polypeptide which consists of the sequence of SEQ ID NO:
• 4;
• the polypeptide which consists of the sequence of SEQ ID NO:
• 5;
• the polypeptide which consists of the sequence of SEQ ID NO:
• 6;
• and
• the polypeptide which consists of the sequence of SEQ ID NO:
• 7,
• wherein each said polypeptide is present in an amount of 100 ng to 2 mg.